Cowen Inc’s Pacific Biosciences PACB Stock Holding History

Cowen Inc’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-144,900	Closed	-$54K	–	528
2019 Q1	$54K	Buy	+144,900	New	+$1.05M	0.01%	267

Other funds holding PACB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return

WIC

Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return

Cowen Inc's PACB Position: Q2 2019 in Review

Cowen Inc increased its Pacific Biosciences (PACB) stake by 154% in Q2 2019, buying an estimated $1.29M and bringing the position to 304,791 shares worth $1.84M. The position accounts for 0.13% of the portfolio, ranked #120.

Cowen Inc first reported a position in PACB in Q1 2014 and has held it in 5 quarters since. 150 funds tracked by Wall St. Rank hold PACB as of Q2 2019.

Cowen Inc held 304,791 shares of Pacific Biosciences worth $1.84M as of Q2 2019.
Cowen Inc bought 184,591 Pacific Biosciences shares in Q2 2019, an estimated $1.29M.
Pacific Biosciences made up 0.13% of Cowen Inc's portfolio in Q2 2019, its #120 holding.
Cowen Inc first reported a position in Pacific Biosciences in Q1 2014 and has held it in 5 quarters since.
150 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.